Form 4: Elanco Animal Health CEO Jeffrey Simmons Acquires Deferred Stock Units
SEC Form 4 Filing
Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.
Summary
- On May 3, 2024, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., acquired 204.6741 deferred stock units.
- These units represent the right to receive one share of Elanco's common stock or the cash equivalent.
- The price per unit was $13.53.
- Following the transaction, Simmons directly owns 1,642.9576 deferred stock units.
- The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The acquisition of deferred stock units by the CEO can be seen as a sign of confidence in the company's future, but it's a routine transaction.
Positives
- The acquisition of deferred stock units by the CEO demonstrates confidence in the company's future performance.
Future Outlook
The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their holdings in the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include deferred stock units as a way to align management's interests with those of shareholders.
- Companies like Zoetis and Merck Animal Health also utilize similar compensation structures for their executives.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals confidence from the CEO.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of transaction: Jeffrey N. Simmons acquired deferred stock units. |
| 05/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.